Smart Syringe Market Size, Share, Price Trends, Analysis 2023-2028

Smart Syringe Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028

Report Format: PDF+Excel | Report ID: SR112023A6399

Buy Now

Market Overview:

The global smart syringe market size reached US$ 8.9 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 13.4 Billion by 2028, exhibiting a growth rate (CAGR) of 7.6% during 2023-2028.

A smart syringe is a medical device engineered with safety mechanisms to prevent reuse and regulate unsafe injection practices. It is incorporated with a read and write chip with preset parameters, ranges, and usage tracking. It is commonly available in variants of auto-disable (AD), passive safety, and active safety syringes. It aids in treating patients with critical disorders and conditions, such as human immunodeficiency virus (HIV), hepatitis A, hepatitis B, and diabetes. It is used for vaccination, drug delivery, and blood specimen collection. As a result, it is utilized in hospitals, clinics, diagnostics, and vaccination centers across the globe.

Smart Syringe Market Trends:

The increasing prevalence of chronic diseases and viral infections among the masses represents one of the major factors positively influencing the demand for smart syringes around the world. It can also be attributed to the growing aging population, which is more prone to severe medical diseases. Moreover, the expanding number of blood-borne infections among the masses is favoring the market growth. In addition, the rising demand for self-injecting medicines is contributing to the market growth. Apart from this, increasing concerns about needle stick injuries and the rising awareness about safe injection practices are offering lucrative growth opportunities to leading players operating in the industry. Furthermore, the expanding number of births and the growing prevalence of various pediatric diseases among adolescents are creating a positive outlook for the market. Additionally, product manufacturers are introducing small-sized, convenient, lightweight with touch screens and Wi-Fi-enabled solutions for easy monitoring. Besides this, rising investments in improving healthcare infrastructure and medical services and extensive research and development (R&D) activities are expected to propel the market growth.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global smart syringe market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on product, age group, application and end user.

Breakup by Product:

Auto-disable Syringes
Active Safety Syringes
Passive Safety Syringes

Breakup by Age Group:

Pediatrics
Adults

Breakup by Application:

Drug Delivery
Vaccination
Blood Specimen Collection

Breakup by End User:

Hospitals and HMOs
Diabetic Patients
Family Practices (Physicians)
Psychiatrics
Others

Breakup by Region:

North America
- United States
- Canada
Asia-Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others
Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Others
Latin America
- Brazil
- Mexico
- Others
Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being AdvaCare Pharma, B. Braun Melsungen AG, Becton, Dickinson and Company, Gerresheimer AG, Merit Medical Systems Inc., Nipro Corporation, Numedico Technologies Pty Ltd., Retractable Technologies Inc. and Terumo Corporation.

Report Coverage:

Report Features	Details
Base Year of the Analysis	2022
Historical Period	2017-2022
Forecast Period	2023-2028
Units	US$ Billion
Segment Coverage	Product, Age Group, Application, End User, Region
Region Covered	Asia Pacific, Europe, North America, Latin America, Middle East and Africa
Countries Covered	United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico
Companies Covered	AdvaCare Pharma, B. Braun Melsungen AG, Becton, Dickinson and Company, Gerresheimer AG, Merit Medical Systems Inc., Nipro Corporation, Numedico Technologies Pty Ltd., Retractable Technologies Inc. and Terumo Corporation.
Customization Scope	10% Free Customization
Report Price and Purchase Option	Single User License: US$ 2499 Five User License: US$ 3499 Corporate License: US$ 4499
Post-Sale Analyst Support	10-12 Weeks
Delivery Format	PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)

Key Questions Answered in This Report

The global smart syringe market was valued at US$ 8.9 Billion in 2022.

We expect the global smart syringe market to exhibit a CAGR of 7.6% during 2023-2028.

The increasing prevalence of viral infections, along with the rising adoption of smart syringes to treat patients with critical disorders and conditions, such as Human Immunodeficiency Virus (HIV), hepatitis A, hepatitis B, diabetes, etc., is primarily driving the global smart syringe market.

The sudden outbreak of the COVID-19 pandemic has led to the inflating demand for smart syringes for providing vaccinations as an immunity booster against the coronavirus infection across several nations.

Based on the product, the global smart syringe market has been divided into auto-disable syringes, active safety syringes, and passive safety syringes. Among these, active safety syringes currently exhibit a clear dominance in the market.

Based on the age group, the global smart syringe market can be categorized into pediatrics and adults. Currently, adults account for the majority of the global market share.

Based on the application, the global smart syringe market has been segregated into drug delivery, vaccination, and blood specimen collection, where drug delivery currently holds the largest market share.

Based on the end user, the global smart syringe market can be bifurcated into hospitals and HMOs, diabetic patients, family practices (physicians), psychiatrics, and others. Currently, hospitals and HMOs exhibit a clear dominance in the market.

On a regional level, the market has been classified into North America, Asia-Pacific, Europe, Latin America, and Middle East and Africa, where North America currently dominates the global market.

Some of the major players in the global smart syringe market include AdvaCare Pharma, B. Braun Melsungen AG, Becton, Dickinson and Company, Gerresheimer AG, Merit Medical Systems Inc., Nipro Corporation, Numedico Technologies Pty Ltd., Retractable Technologies Inc., and Terumo Corporation.

Need more help?

Speak to our experienced analysts for insights on the current market scenarios.
Include additional segments and countries to customize the report as per your requirement.
Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
For further assistance, please connect with our analysts.

Select License Type

Single User License $2499
Five User License $3499
Corporate License $4499

Inquire Before Buying

Speak to an Analyst

Request Brochure

Request Customization

Benefits of Customization

Personalize this research

Triangulate with your data

Get data as per your format and definition

Gain a deeper dive into a specific application, geography, customer, or competitor

Any level of personalization

Get in Touch With Us

UNITED STATES

Phone: +1-631-791-1145

INDIA

Phone: +91-120-433-0800

UNITED KINGDOM

Phone: +44-753-713-2163

Email: sales@imarcgroup.com

Client Testimonials

IMARC made the whole process easy. Everyone I spoke with via email was polite, easy to deal with, kept their promises regarding delivery timelines and were solutions focused. From my first contact, I was grateful for the professionalism shown by the whole IMARC team. I recommend IMARC to all that need timely, affordable information and advice. My experience with IMARC was excellent and I can not fault it.

The IMARC team was very reactive and flexible with regard to our requests. A very good overall experience. We are happy with the work that IMARC has provided, very complete and detailed. It has contributed to our business needs and provided the market visibility that we required

We were very happy with the collaboration between IMARC and Colruyt. Not only were your prices competitive, IMARC was also pretty fast in understanding the scope and our needs for this project. Even though it was not an easy task, performing a market research during the COVID-19 pandemic, you were able to get us the necessary information we needed. The IMARC team was very easy to work with and they showed us that it would go the extra mile if we needed anything extra

Last project executed by your team was as per our expectations. We also would like to associate for more assignments this year. Kudos to your team.

We would be happy to reach out to IMARC again, if we need Market Research/Consulting/Consumer Research or any associated service. Overall experience was good, and the data points were quite helpful.

Arabian Plastic Manufacturing Company Ltd.

The figures of market study were very close to our assumed figures. The presentation of the study was neat and easy to analyse. The requested details of the study were fulfilled. My overall experience with the IMARC Team was satisfactory.

The overall cost of the services were within our expectations. I was happy to have good communications in a timely manner. It was a great and quick way to have the information I needed.

My questions and concerns were answered in a satisfied way. The costs of the services were within our expectations. My overall experience with the IMARC Team was very good.

I agree the report was timely delivered, meeting the key objectives of the engagement. We had some discussion on the contents, adjustments were made fast and accurate. The response time was minimum in each case. Very good. You have a satisfied customer.

We would be happy to reach out to IMARC for more market reports in the future. The response from the account sales manager was very good. I appreciate the timely follow ups and post purchase support from the team. My overall experience with IMARC was good.

IMARC was a good solution for the data points that we really needed and couldn't find elsewhere. The team was easy to work, quick to respond, and flexible to our customization requests.